New Results
Pharmacologically modified pluripotent stem cell-based cancer vaccines with anti-metastatic potential
Masae Heront-Kishi, Afag Asgarova, Christophe Desterke, Diana Chaker, Marie-Ghislaine de Goër de Herve, View ORCID ProfileAli G Turhan, Annelise Bennaceur-Griscelli, Frank Griscelli
doi: https://doi.org/10.1101/2020.05.27.118471
Masae Heront-Kishi
1Institut National de la Santé et de la Recherche Médicale (INSERM) U935-Human Pluripotent Stem Cell Core Facility, ESTeam Paris Sud-INGESTEM, Villejuif, France
Afag Asgarova
1Institut National de la Santé et de la Recherche Médicale (INSERM) U935-Human Pluripotent Stem Cell Core Facility, ESTeam Paris Sud-INGESTEM, Villejuif, France
Christophe Desterke
1Institut National de la Santé et de la Recherche Médicale (INSERM) U935-Human Pluripotent Stem Cell Core Facility, ESTeam Paris Sud-INGESTEM, Villejuif, France
2Université Paris-Saclay, Faculté de Médecine, Kremlin Bicêtre, France
Diana Chaker
1Institut National de la Santé et de la Recherche Médicale (INSERM) U935-Human Pluripotent Stem Cell Core Facility, ESTeam Paris Sud-INGESTEM, Villejuif, France
Marie-Ghislaine de Goër de Herve
3Institut National de la Santé et de la Recherche Médicale (INSERM) U1184, Immunology of Viral Infection and Auto-immune Diseases, Normal and Pathological T Memory, Faculté de Médecine Paris-Sud, Kremlin-Bicêtre, France
Ali G Turhan
1Institut National de la Santé et de la Recherche Médicale (INSERM) U935-Human Pluripotent Stem Cell Core Facility, ESTeam Paris Sud-INGESTEM, Villejuif, France
2Université Paris-Saclay, Faculté de Médecine, Kremlin Bicêtre, France
4APHP Paris-Saclay Service d’Hématologie, Hôpital Universitaire Paris Sud, (AP-HP), Kremlin Bicêtre, France
Annelise Bennaceur-Griscelli
1Institut National de la Santé et de la Recherche Médicale (INSERM) U935-Human Pluripotent Stem Cell Core Facility, ESTeam Paris Sud-INGESTEM, Villejuif, France
2Université Paris-Saclay, Faculté de Médecine, Kremlin Bicêtre, France
4APHP Paris-Saclay Service d’Hématologie, Hôpital Universitaire Paris Sud, (AP-HP), Kremlin Bicêtre, France
Frank Griscelli
1Institut National de la Santé et de la Recherche Médicale (INSERM) U935-Human Pluripotent Stem Cell Core Facility, ESTeam Paris Sud-INGESTEM, Villejuif, France
2Université Paris-Saclay, Faculté de Médecine, Kremlin Bicêtre, France
5Université Paris Descartes, Sorbonne Paris Cité, Faculté des Sciences Pharmaceutiques et Biologiques, Paris, France
Article usage
Posted July 16, 2020.
Pharmacologically modified pluripotent stem cell-based cancer vaccines with anti-metastatic potential
Masae Heront-Kishi, Afag Asgarova, Christophe Desterke, Diana Chaker, Marie-Ghislaine de Goër de Herve, Ali G Turhan, Annelise Bennaceur-Griscelli, Frank Griscelli
bioRxiv 2020.05.27.118471; doi: https://doi.org/10.1101/2020.05.27.118471
Pharmacologically modified pluripotent stem cell-based cancer vaccines with anti-metastatic potential
Masae Heront-Kishi, Afag Asgarova, Christophe Desterke, Diana Chaker, Marie-Ghislaine de Goër de Herve, Ali G Turhan, Annelise Bennaceur-Griscelli, Frank Griscelli
bioRxiv 2020.05.27.118471; doi: https://doi.org/10.1101/2020.05.27.118471
Subject Area
Subject Areas
- Biochemistry (11697)
- Bioengineering (8714)
- Bioinformatics (29118)
- Biophysics (14924)
- Cancer Biology (12047)
- Cell Biology (17347)
- Clinical Trials (138)
- Developmental Biology (9405)
- Ecology (14138)
- Epidemiology (2067)
- Evolutionary Biology (18260)
- Genetics (12214)
- Genomics (16759)
- Immunology (11838)
- Microbiology (27986)
- Molecular Biology (11545)
- Neuroscience (60780)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3228)
- Physiology (4937)
- Plant Biology (10381)
- Synthetic Biology (2876)
- Systems Biology (7332)
- Zoology (1642)